Ongoing clinical trial by University of Colorado Cancer Center investigators is evaluating the ability of an inhaled form of the pulmonary hypertension drug iloprost to prevent lung cancer.
14-Jun-2017 3:05 PM EDT Add to Favorites
University of Colorado Cancer Center study pinpoints promising link in the chain of hedgehog signaling that, when broken, could reduce the metastatic potential of breast cancer.
12-Jun-2017 12:05 PM EDT Add to Favorites
Worldwide phase II clinical trial results presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2017 show the promise of the second-generation drug dasatinib against pediatric CML. Of 113 pediatric patients studied, 75...
31-May-2017 4:05 PM EDT Add to Favorites
Study presented at ASCO 2017 shows that only 9 percent of 259 evaluated AML patients received all seven of the NCCN-recommended genetic tests.
31-May-2017 5:05 PM EDT Add to Favorites
FDA approves brigatinib as a second-line therapy for ALK-positive non-small cell lung cancer
17-May-2017 11:05 AM EDT Add to Favorites
A University of Colorado Cancer Center clinical trial is now recruiting prostate cancer patients who would otherwise be on a watch-and-wait protocol to test the ability of grape seed extract to slow the rise of prostate-specific antigen (PSA), a...
16-May-2017 12:45 PM EDT Add to Favorites
Patients with castration resistant prostate cancer (CRPC) usually have a poor prognosis. In part, this is due to the cancer’s ability to resist anti-androgen therapy. A University of Colorado Cancer Center study published today [May 3] in...
15-May-2017 12:00 PM EDT Add to Favorites
Small trial uses chloroquine to nix the process of "autophagy" that some cancer cells use to resist treatment, resensitzing glioblastoma to targeted therapy
19-Apr-2017 10:05 AM EDT Add to Favorites
27-Jul-2015 11:05 AM EDT
An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT